Exelixis, a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care, announced that the US FDA has notified the company that the ...
Marvel Biosciences announces new additional data from Rett syndrome study; plans to discuss results with US FDA: Calgary, Alberta Thursday, November 28, 2024, 18:00 Hrs [IST] Calg ...
PTC Therapeutics’ phase 2 CardinALS study of utreloxastat in ALS patients fails to meet primary endpoint: Warren, New Jersey Thursday, November 28, 2024, 15:00 Hrs [IST] PTC The ...
Boehringer Ingelheim announced the launch of the latest advancement in Marek’s disease vaccines in India. This next generation vaccine offers enhanced protection through an innovative controlled ...
Fedo.ai with Electronic Village to empower health benchmarking across the GCC Region: Our Bureau, Bengaluru Thursday, November 28, 2024, 14:45 Hrs [IST] Fedo.ai, an AI-driven plat ...
Nine UK universities have been selected to make up the new NIHR Challenge Maternity Disparities Consortium, with the aim of tackling inequalities in maternity outcomes. The research carried out by the ...
Valneva submits label extension application to US FDA for chikungunya vaccine, IXCHIQ: Saint Herblain, France Thursday, November 28, 2024, 16:00 Hrs [IST] Valneva SE, a specialty ...
Idorsia enters into exclusive negotiations with an undisclosed party for global rights to aprocitentan: Allschwil, Switzerland Thursday, November 28, 2024, 14:00 Hrs [IST] Idorsia ...